The spurt of newer technologies in the U.S. medical laser devices market has made possible the treatment of various critical conditions, which were previously difficult to treat. For instance, lasers are now widely used among patients who cannot undergo a bypass surgery. Similarly, the quick rehabilitation period and minimal post-operative pain involved with laser in situ keratomileusis (LASIK) procedures in ophthalmology has contributed to its popularity. Newer advancements such as Customcornea enable sophisticated, vision correction techniques that are capable of providing 'customized' treatments for a specific patient.

This research from Frost & Sullivan examines the competitive landscape and key trends of the aesthetic, cardiology, ophthalmology, and urology segments of the U.S. medical lasers market. It provides an insight into the drivers and restraints affecting each of these segments and outlines the winning strategies adopted by leading participants. It also offers solutions to overcome the challenges facing the industry.

Rise in Age-related Diseases Likely to Enhance Sales

There has been a considerable increase in demand from the growing baby boomer population for laser treatments. Age related diseases such as presbyopia, macular degeneration, and diabetic retinopathy have positively impacted the ophthalmology segment. Selective laser trabeculoplasty (SLT), an outpatient procedure for the treatment of glaucoma, is yet another promising area. In the urology segment, diode lasers and holmium YAG are finding acceptance in the treatment of benign prostatic hyperplasia (BPH), a serious malady among elderly men.

The aesthetic segment, is yet another area that is slated for impressive growth. "The psychological pressure to look good will increase the demand for laser treatments in this segment," says the analyst. "Skin-resurfacing technology among the older generation, laser hair removal and treatment of skin conditions such as psoriasis, are likely to boost market revenue."

Sustaining Demand for New Modalities Integral to Future Growth

The mounting demand for lasers has been met by a corresponding surge of innovative technologies. For instance, laser angioplasty and laser cardiac lead removal techniques equip cardiologists with additional tools to treat chronic cardiovascular conditions such as peripheral vessel thrombosis and chronic occlusion of coronary arteries. However, though prospects seem bright, participants with upcoming technologies point out that contending with established techniques is extremely difficult.

For instance, extracorporeal shock wave lithotripsy (ESWL) has become an almost standardised form of treatment for renal stones. "It would be extremely difficult to convince surgeons to adopt the cost-effective laser lithotripsy method instead of ESWL," says the analyst. "This is because surgeons tend to make huger profits from being reimbursed for the more expensive older procedures." Additionally, new modalities require heavy investments in the initial stages. Manufacturers need to address these challenges that are likely to curb uptake.